MED
Medifast IncPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Independent active earning coaches | 14,000 | first quarter 2026 | — |
|
|
|||
| Revenue per active earning coach | $5,432 | first quarter 2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Personal Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MED
this stock
Medifast Inc
|
$121.87M | +2.6% | +66.1% | — | 19.4% |
|
ANDG
Andersen Group Inc.
|
$35.66B | +40.2% | +14.6% | — | 1.9% |
|
ROL
Rollins Inc
|
$20.89B | -27.5% | +8.8% | 39.8 | 1.9% |
|
SCI
Service Corp International
|
$10.85B | +1.2% | +2.9% | 20.7 | 5.0% |
|
FTDR
Frontdoor, Inc.
|
$5.51B | +36.1% | +13.6% | 22.4 | 4.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MED | +7.5% | -10.5% | -0.6% | +3.3% | +2.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +6.0% | -9.2% | -8.7% | +3.6% | -6.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.